← Back to screener

CYTOKINETICS INC CYTK

Rank #1941 · Nasdaq · $7.8B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
38.2
P/E
-14.9
P/B
-72.64
ROE
487.7%
Op. Margin
-6589.7%
Debt Ratio
-1425%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -14.9x, P/B -72.64x. Ranks in the top 90% of the universe.

Profitability ★★★☆☆
Average

ROE 487.7%. Ranks in the top 50% of the universe.

Safety ★★★★★
Excellent

Debt ratio -1425%. Ranks in the top 1% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆
Poor

Revenue decline of 92.0% year over year. Ranks in the top 99% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.1B$0.0B$-0.0B$-0.0B32.0-373
2012$0.0B$-0.0B$-0.0B$-0.0B-1926.1-229
2013$0.0B$-0.0B$-0.0B$0.1B-1199.111
2014$0.0B$-0.0B$-0.0B$0.0B-535.260
2015$0.0B$-0.0B$-0.0B$0.1B-110.658
2016$0.0B$-0.0B$-0.0B$0.1B-31.486
2017$0.0B$-0.0B$-0.0B$0.1B-130.582
2018$0.0B$-0.1B$-0.1B$0.1B-848.3196
2019$0.0B$-0.1B$-0.1B$0.1B-282.3169
2020$0.0B$-0.1B$-0.1B$0.1B-282.3274
2021$0.0B$-0.1B$-0.1B$0.0B-368.01621
2022$0.1B$-0.1B$-0.1B$-0.0B-168.3-5463
2023$0.1B$-0.2B$-0.2B$0.1B-264.5990
2024$0.1B$-0.3B$-0.4B$0.2B-342.8496
2025$0.0B$-0.5B$-0.5B$-0.1B-6589.7-1425

← See the full screener